Disclosed are rifamycin derivatives having antibacterial activities, wherein the compounds have the following general formula:
wherein:
R is hydrogen or acetyl; R
1
and R
2
are independently selected from the group consisting of hydrogen, (C
1-4
)alkyl, benzyloxy, mono- and di-(C
1-3
)alkylamino-(C
1-4
)alkyl, (C
1-3
)alkoxy, (C
1-4
)alkyl, hydroxy-methyl, hydroxy-(C
2-4
)-alkyl, and nitro or R
1
and R
2
taken together with two consecutive carbon atoms of the pyridine nucleus form a benzene ring optionally substituted by one or two methyl or ethyl groups and R
3
is hydroxyalkyl(C
1-4
). In addition, processes to obtain these compounds are described.
                            揭示了具有抗菌活性的
利福霉素衍
生物,其中化合物具有以下一般式:其中:R为氢或乙酰基;R1和R2分别选自氢、(C1-4)烷基、苄氧基、单烷基和双烷基
氨基-(C1-4)烷基、(C1-3)烷氧基、(C1-4)烷基、羟基甲基、羟基-(C2-4)-烷基、硝基或R1和R2连在一起与
吡啶环的两个相邻碳原子形成苯环,该苯环可选择地被一个或两个甲基或乙基基团取代,R3为羟基烷基(C1-4)。此外,还描述了获得这些化合物的过程。